Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome-Reference-Cited by-同舟云学术

Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome

Published:2023-02-03 Issue:2 Volume:13 Page:285
ISSN:2075-4426
Container-title:Journal of Personalized Medicine
language:en
Short-container-title:JPM

Author:

Ho Teresa T.¹^ORCID,Noble Melissa¹,Tran Bao Anh¹,Sunjic Katlynd¹,Gupta Sheeba Varghese²,Turgeon Jacques³^ORCID,Crutchley Rustin D.⁴^ORCID

Affiliation:

1. Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL 33612, USA

2. Department of Pharmaceutical Sciences, University of South Florida College of Pharmacy, Tampa, FL 33612, USA

3. Precision Pharmacotherapy Research & Development Institute, Tabula Rasa HealthCare, Moorestown, NJ 08057, USA

4. Department of Pharmacotherapy, Washington State University, College of Pharmacy and Pharmaceutical Sciences, Yakima, WA 98901, USA

Abstract

Diazepam is a benzodiazepine widely prescribed for the management of patients with severe alcohol withdrawal syndrome to prevent agitation, withdrawal seizures, and delirium tremens. Despite standard dosing of diazepam, a subset of patients experience refractory withdrawal syndromes or adverse drug reactions, such as impaired motor coordination, dizziness, and slurred speech. The CYP2C19 and CYP3A4 enzymes play a key role in the biotransformation of diazepam. Given the highly polymorphic nature of the CYP2C19 gene, we reviewed the clinical impact of variants in the CYP2C19 gene on both the pharmacokinetics of diazepam and treatment outcomes related to the management of alcohol withdrawal syndrome.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Link

https://www.mdpi.com/2075-4426/13/2/285/pdf

Reference44 articles.

1. (2023, January 20). Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health, Available online: https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf.

2. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.].

3. Alcohol-use disorders;Schuckit;Lancet,2009

4. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients;Dixit;Pharmacotherapy,2016

5. ASAM Quality Improvement Council (2020). The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. J. Addict. Med., 14, e280.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms;Genes;2023-11-06

2. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy;Genes;2023-05-16